Clinical Research Directory
Browse clinical research sites, groups, and studies.
Induction of Labor in Morbidly Obese Patients
Sponsor: University of Maryland, Baltimore
Summary
The goal of this randomized control trial is to compare different doses of Misoprostol (25 mcg vs 50 mcg) in induction of labor (IOL) in morbidly obese patients with BMI \>40. It is known that morbid obesity is a risk factor for failed IOL and ultimately cesarean delivery (CD.) If the rates of vaginal delivery in this population can improve, then surgical morbidity can be reduced in these patients.
Official title: Induction of Labor in Morbidly Obese Patients: Comparison of 50 mcg and 25 mcg Misoprostol - A Randomized Control Trial
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
162
Start Date
2024-07-15
Completion Date
2026-10
Last Updated
2025-07-03
Healthy Volunteers
No
Conditions
Interventions
Misoprostol
Participants will receive with 25 mcg or 50 mcg vaginal misoprostol every 4 hours.
Locations (1)
University of Maryland Medical Center
Baltimore, Maryland, United States